AIM IMMUNOTECH INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss
AIM IMMUNOTECH INC. (AIM) had Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss of $1.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss · last filed 2018-03-30
- 2017-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $1.00K.
- 2016-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $13.00K.
- 2015-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $180.00K.
- 2015-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $401.00K.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2017-09-30 | $1.00K 10-Q · filed 2017-11-14 |
| 2016-12-31 | $13.00K 10-K · filed 2018-03-30 |
| 2015-12-31 | $180.00K 10-K · filed 2017-03-31 |
| 2015-09-30 | $401.00K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $186.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $54.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $160.00K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |